EAM
Eagle Asset Management Portfolio holdings
AUM
$19.6B
This Quarter Return
+13.62%
1 Year Return
+41.7%
3 Year Return
+53.51%
5 Year Return
+214.43%
10 Year Return
+692.81%
AUM
$19.4B
AUM Growth
+$19.4B
(+10%)
Cap. Flow
-$110M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
10.56%
Holding
615
New
52
Increased
139
Reduced
368
Closed
48
Top Buys
| 1 |
Caesars Entertainment
CZR
|
$107M |
| 2 |
FIVE9
FIVN
|
$68.8M |
| 3 |
Amgen
AMGN
|
$61.7M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$58.8M |
| 5 |
Broadcom
AVGO
|
$47.1M |
Top Sells
| 1 |
CZR
Caesars Entertainment Corporation
CZR
|
$104M |
| 2 |
Teleflex
TFX
|
$72.9M |
| 3 |
Chipotle Mexican Grill
CMG
|
$64.6M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
$49.8M |
| 5 |
IPG Photonics
IPGP
|
$48.3M |
Sector Composition
| 1 | Technology | 24.48% |
| 2 | Healthcare | 22.46% |
| 3 | Industrials | 13.89% |
| 4 | Consumer Discretionary | 11.3% |
| 5 | Financials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Exact Sciences
EXAS
$9.32B
| – | – |
-39,183
| Closed | -$3.37M |
|
602
eHealth
EHTH
$124M
| – | – |
-207,690
| Closed | -$19.8M |
|
603
Columbia Sportswear
COLM
$3.09B
| – | – |
-14,784
| Closed | -$1.18M |
|
604
Capital One
COF
$141B
| – | – |
-10,558
| Closed | -$658K |
|
605
Core Laboratories
CLB
$549M
| – | – |
-134,578
| Closed | -$2.61M |
|
606
Cadence Design Systems
CDNS
$94B
| – | – |
-14,745
| Closed | -$1.39M |
|
607
Berkshire Hathaway Class B
BRK.B
$1.08T
| – | – |
-10,108
| Closed | -$1.79M |
|
608
Builders FirstSource
BLDR
$15B
| – | – |
-1,112,803
| Closed | -$22.8M |
|
609
AvalonBay Communities
AVB
$27.1B
| – | – |
-9,124
| Closed | -$1.4M |
|
610
AptarGroup
ATR
$8.89B
| – | – |
-56,972
| Closed | -$6.22M |
|
611
ANI Pharmaceuticals
ANIP
$2.03B
| – | – |
-62,046
| Closed | -$1.94M |
|
612
American Tower
AMT
$91.8B
| – | – |
-6,983
| Closed | -$1.77M |
|
613
ACI Worldwide
ACIW
$5.04B
| – | – |
-147,163
| Closed | -$3.89M |
|
614
Acadia Pharmaceuticals
ACAD
$4.3B
| – | – |
-59,931
| Closed | -$2.89M |
|